Business news with perspective

Windward Risk Managers announces rate cuts, but the real story lies in the legislative overhaul that made them possible. Is this true relief or a fragile stability?

The fintech firm's Clara Connect platform signals a strategic pivot from direct lending to a powerful, automated network for small business capital delivery.

The gene therapy firm's inclusion in key indexes is more than a financial win; it's a market validation of a deep scientific pipeline and savvy strategy.

A new report from Adobe's Semrush on 126M AI prompts shows brands are losing control of their narrative. Visibility is no longer about SEO, but about trust.

Elounda Hills' record sales reveal more than a hot property market; they signal Crete's transformation into a global hub, powered by new infrastructure and a new vision for luxury.

Canada's flag carrier rolls out a patriotic summer campaign, but operational headwinds, airport chaos, and labor unease threaten a smooth landing.

Star Therapeutics' innovative drug VGA039 lands a $2B deal with Incyte, signaling a major shift in treating the most common inherited bleeding disorder.

While May's headline delinquency numbers seem calm, a surge in serious defaults and foreclosures to multi-year highs reveals growing stress for homeowners.

Ninepoint's new ETF offers a high-risk, high-reward path to investing in AI giant Anthropic, using leverage and options. Is this the future of AI investing?

HCW Biologics executes a reverse stock split to avoid Nasdaq delisting. Is it a necessary survival tactic or a warning sign for investors? We analyze.

Medicenna Therapeutics is advancing its promising cancer immunotherapies, MDNA11 and MDNA113, while navigating a tight financial runway. Can it deliver?

Maalexi just closed a $2.8M round led by Saudi's top insurer to build a regulated crypto exchange for crops. Is this the future of global food security?

FactSet's new AI tool promises to democratize portfolio analytics. But in a high-stakes industry, can it deliver powerful insights without sacrificing trust?

Lupin's generic approval for Xtandi isn't just about price. Its new single-pill dose could transform patient care and challenge Astellas's market dominance.

CDT Equity's bet on SarborgQ signals a new era where quantum computing and AI accelerate drug formulation, creating a high-stakes race for intellectual property.

Asia's largest home furnishing firm just launched an AI that designs entire homes in 30 minutes, linking plans directly to its massive robot factories.

New research reveals that even with pensions, government workers need more. Financial guidance, digital tools, and literacy are key to true confidence.

reAlpha Mortgage is ditching traditional commissions for a flat-fee model with stock options and AI. A bold commercialization play in the war for loan officers.

A small biotech's dual-front war on cancer reveals a powerful new playbook: leveraging elite partnerships to pioneer a preventative vaccine and a novel CAR-T.

A new customs deal with Uruguay isn't just stopping smugglers. It's a key move to secure supply chains, de-risk a $317M trade route, and pave the way for a larger FTA with South America's MERCOSUR bloc.